Background. Women with diabetes mellitus type I and type II need effective contraception for personal and medical reasons. Long acting reversible contraceptive (LARC) methods are among the most efficient and cost-effective methods. Study Design. We searched the Popline, PubMed, and clinicaltrials.gov databases from 1961 to March 2013 for studies on the efficacy of the IUD in diabetic women and ...

OBJECTIVES When ulipristal acetate (UPA) was introduced into the Contraceptive and Sexual Health Services service in June 2011 an algorithm was developed to guide method selection. The aim was to encourage clinicians to assess risk and to offer a copper intrauterine device (IUD) as first-line choice with hormonal methods as second-line choice. METHODS UPA was the second-line choice for presen...

BACKGROUND Use of the intrauterine device (IUD) in the United States has recently increased. New evidence for women with employer-sponsored health insurance permits analysis of variation and trends in such use. STUDY DESIGN A retrospective analysis of annual IUD insertion rates between 2002 and 2008 was conducted by evaluating claims from the MarketScan® Commercial Research Databases for US w...

BACKGROUND The levonorgestrel-releasing IUD can help the treatment of dysmenorrhea by reducing the synthesis of endometrial prostaglandins as a conventional treatment. OBJECTIVE This study was performed to assess the frequency of dysmenorrhea, satisfaction and quality of life in women using Mirena IUDs as compared to those using copper IUDs. MATERIALS AND METHODS This double-blind randomize...

Background: Infection caused by Neisseria Gonorrhoeae increases the risk of pelvic inflammatory disease (PID). Gonococcal PID tends to be clinically more severe than non-gonococcal ones. The main is present two cases gonococcal PID, with rapid clinical and analytic progression, leading sepsis, but without imaging manifestations. Clinical presentation: 1. 41-year-old patient replacement intraute...

BACKGROUND Insertion of an intrauterine device (IUD) at different times or by different routes during the postpartum period may increase the risk of complications. METHODS We searched Medline, Lilacs and Cochrane Collaboration databases for articles in any language, between database inception until December 2008, which compared outcomes of postpartum IUD insertion time intervals. Search terms...

Melasma is a common acquired hypermelanosis of the skin that has been associated with several etiologic factors including ultraviolet light exposure, pregnancy, and oral contraceptives (OCPs) (1). Forty-one percent of women surveyed in one study had onset of melasma after pregnancy, and 25% after starting an OCP (2). Women who develop melasma during pregnancy may be more susceptible to developi...

To review published evidence on Comparative Effectiveness and Humanistic Burden of Hormonal LARCs Levonorgestrel-IUD (LNG-IUD) Etonogestrel Subdermal Implant (ESI). A systematic literature search was performed using MEDLINE via PubMed, LILACS CENTRAL. strategy formulated studies up to 2021 were included. Two reviewers independently selected the studies, summarized data, assessed risk bias. Crit...

OBJECTIVE To evaluate the effectiveness of the contraceptive implant and the 52-mg hormonal intrauterine device (IUD) in women using the method beyond the current U.S. Food and Drug Administration (FDA)-approved duration of 3 and 5 years, respectively. METHODS Women willing to continue using their implant or 52-mg levonorgestrel IUD beyond the FDA-approved duration were followed prospectively...

OBJECTIVE To estimate 12-month satisfaction and continuation rates of intrauterine device (IUD) and implant users enrolled in the Contraceptive CHOICE Project and compare these measures with women using the oral contraceptive pills (OCPs). METHODS We analyzed 12-month data from the first 5,087 participants enrolled in a prospective cohort study of women in the St. Louis region offered contrac...